Azoulay Salomon 4
4 · MBX Biosciences, Inc. · Filed Sep 13, 2024
Insider Transaction Report
Form 4
Azoulay Salomon
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-09-12+45,011→ 45,011 totalExercise: $16.00Exp: 2034-09-11→ Common Stock (45,011 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option vest and become exercisable on September 12, 2025, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.